Quantum Data’s findings show that, in candidate screening against the DYRK1A kinase, a quantum-processor-derived model and a traditional tabular QSAR model proposed different compounds. The study evaluated 354 compounds and labeled activity at an IC50 of no more than 1 μM. The disagreement between the two methods persisted across different data partitions, but the study did not claim quantum advantage.
Source:Quantum Zeitgeist · Read original
Leave a Reply